Definitive Healthcare Corp. (DH)

NASDAQ: DH · USD

$1.13

+0.02 (+2.3%)· Recorded snapshot

Market cap	163.7M
Revenue (ttm)	232.7M
Net income (ttm)	-168.2M
EPS (ttm)	-$1.61
Shares out	144.8M
P/E (forward)	6.4x
Volume	454,808
Beta	1.40

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 232.7M
Net income (ttm): -168.2M
EPS (ttm): -$1.61
P/E (forward): 6.4x
Market cap: 163.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	نگه‌داری

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E6.4

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-78.4

P25 n/aP50 n/aP75 n/a

ROIC-2.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All DH indicators

Market & fundamental data

Available fields

234

Groups with data

Currency

USD

Showing 234 of 234 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001861795
Company name	Definitive Healthcare Corp.
Country	United States
Country code	US
CUSIP number	24477E103
Earnings date	2026-11-09
Earnings time	amc
Employees	686
Employees change	-96
Employees growth	-12.28%
Enterprise value	$146.9M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2011
Industry	Health Information Services
IPO date	2021-09-15
Is primary listing	Yes
Is SPAC	No
ISIN number	US24477E1038
Last 10-K release date	2026-02-26
Last earnings date	2026-08-10
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$163.7M
Market cap category	Micro-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$1.13
Price currency	USD
Sector	Healthcare
SIC code	7372
Stock price date	2026-10-28
Symbol	DH
U.S. state	Massachusetts
Website	https://www.definitivehc.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	4.71x
Earnings yield	-142.6%
EV/EBITDA	4.06x
EV/FCF	5.02x
EV/Sales	0.62x
FCF / EV yield	19.93%
FCF yield	17.85%
Forward EV/Sales	0.65x
Forward P/E	6.43x
Forward P/S	0.72x
Industry forward P/E	34.62x
P/(FCF - SBC) ratio	49.35x
P/(OCF - SBC) ratio	9.94x
P/B ratio	0.81x
P/FCF ratio	5.6x
P/OCF ratio	3.86x
P/S ratio	0.69x
Price/EBITDA ratio	4.53x
Sector forward P/E	23.53x
Sector P/E	51.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-8.45%
EBITDA margin	15.18%
FCF margin	12.27%
Gross margin	83.76%
Operating margin	-8.45%
Pretax margin	-102.3%
Profit margin	-72.28%
Profit per employee	$-245,184
Revenue per employee	$339,219
ROA	-1.94%
ROA (5Y)	-0.91%
ROCE	-5.34%
ROE	-78.37%
ROE (5Y)	-26.75%
ROIC	-2.6%
SBC / revenue	10.88%
Tax / revenue	-1.42%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	1
EPS growth years	1
FCF growth	-30.79%
FCF growth (Q)	21.44%
FCF growth (QoQ)	1.82%
FCF growth 3Y	5.06%
FCF growth 5Y	2.14%
Gross profit growth	-4.89%
Gross profit growth (Q)	-11.88%
Gross profit growth 3Y	-2.11%
Gross profit growth 5Y	9.14%
Net income growth quarters	1
Net income growth years	1
OCF growth	-34.18%
OCF growth (Q)	23.13%
OCF growth (QoQ)	-0.93%
OCF growth 3Y	7.38%
OCF growth 5Y	5.69%
Revenue growth	-4.99%
Revenue growth (Q)	-9.14%
Revenue growth (QoQ)	-1.31%
Revenue growth 3Y	-0.77%
Revenue growth 5Y	10.62%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-12.9M
Depreciation and amortization	$55M
EBIT	$-19.7M
EBITDA	$35.3M
EPS	$-1.61
FCF per share	$0.20
Financing cash flow	$-30.3M
Free cash flow	$28.6M
Free cash flow minus SBC	$3.2M
Gross profit	$194.9M
Income taxes	$-3.3M
Investing cash flow	$79.2M
Net borrowing	$-8.8M
Net cash flow	$89.9M
Net income	$-168.2M
Operating cash flow minus SBC	$16.1M
Operating income	$-19.7M
Revenue	$232.7M
Stock-based compensation	$25.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-1.51
Book value per share	$1.36
Debt / EBITDA	4.46
Debt / equity	0.89
Debt / FCF	5.85
Interest coverage	-1.77
Long-term assets	$256.7M
Long-term liabilities	$179.9M
Net cash (debt)	$16.7M
Net cash / market cap	10.47%
Net cash growth	161.87%
Net debt / EBITDA	-0.47
Net debt / equity	-0.09
Net debt / FCF	-0.59
Piotroski F-Score	6
Property, plant and equipment	$19M
Shareholders' equity	$187.9M
Tangible book value	$-78.1M
Tangible book value per share	$-0.73
Total assets	$496.8M
Total cash	$183.8M
Total debt	$167.1M
Total liabilities	$309M
WACC	8.52%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.37
Current assets	$240.1M
Current liabilities	$129.1M
Current ratio	1.86
Net working capital	$-61.4M
Quick ratio	1.67
Working capital	$111M
Working capital turnover	2.23

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	7.41%
Dividend yield	0%
Shareholder yield	7.41%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$0.90
1D price change	2.26%
1M price change	19.05%
1M total return	19.05%
1W price change	-0.44%
1W total return	-0.44%
1Y price change	-62.12%
1Y return CAGR	-62.15%
1Y total return	-62.12%
20-day SMA	$1.03
200-day SMA	$1.09
3M price change	67.01%
3M total return	67.01%
3Y price change	-81.06%
3Y return CAGR	-42.56%
3Y total return	-81.06%
50-day SMA	$0.96
50-day SMA vs 200-day SMA	50under200
52-week high	$3.00
52-week high date	2025-11-28
52-week low	$0.61
52-week low date	2026-08-14
5Y price change	-96.88%
5Y return CAGR	-50.02%
5Y total return	-96.88%
6M price change	11.39%
6M total return	11.39%
All-time high	$50.30
All-time high date	2021-09-17
All-time low	$0.61
All-time low date	2026-08-14
Average true range (ATR)	$0.06
Average volume	322.2K
Beta (1Y)	1.47
Beta (2Y)	1.48
Beta (5Y)	1.4
Change from 52-week high	-62.33%
Change from 52-week low	85.16%
Change from all-time high	-97.76%
Change from all-time low	84.34%
Change from open	0.89%
Day's gap	1.36%
Dollar volume	$513,933
High price	$1.15
Low price	$1.11
Monthly RSI	29.44
Open price	$1.12
Position in 52-week range	62.5%
Premarket change	-0.45%
Premarket close	$1.11
Premarket price	$1.10
Previous close	$1.11
Price vs 150-day SMA	25.63%
Price vs 20-day SMA	9.54%
Price vs 200-day SMA	3.12%
Price vs 50-day SMA	16.92%
Relative volume	1.41
Return from IPO open	-97.03%
Return from IPO price	-95.91%
RSI	66.42
Sharpe ratio	-0.93
Sharpe ratio (3Y)	-0.48
Sharpe ratio (5Y)	-0.72
Sortino ratio	-1.24
Sortino ratio (3Y)	-0.58
Sortino ratio (5Y)	-0.88
Volume	454.8K
Weekly RSI	52.29
YTD price change	-60.8%
YTD total return	-60.8%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	40.4M
Float percentage	27.92%
Shares change (QoQ)	1.08%
Shares change (YoY)	-7.41%
Shares held by insiders	3.49%
Shares held by institutions	24.08%
Shares outstanding	144.8M
Short % of float	4.76%
Short % of shares	1.33%
Short ratio	1.3 days

Deeper analysis on DH

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Frequently asked questions

About this DH report

Is a complete DH research report available?

No complete published report is available for Definitive Healthcare Corp. (DH) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Definitive Healthcare Corp. (DH)

Price

Financial snapshot

Fair-value bridge

Latest news · DH

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All DH indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on DH

Frequently asked questions